Insider · CIK 0001417976

Galligan Andrew H

Reports to the SEC for 5 companies · SUNNYVALE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001417976

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-04	OOMAOOMA INCA Award	Director	AAward	+9,743 sh	—	—	250,824
2026-04-28	Arcellx, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,784 sh	—	—	0
2026-04-28	Arcellx, Inc.U Disposition from Tender	Director	UDisposition from Tender	−5,000 sh	—	—	0
2026-04-28	Arcellx, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16.8K sh	—	—	0
2025-06-23	OOMAOOMA INCS Sale	Director	SSale	−12.4K sh	$12.43	−$154K	241,081
2025-06-05	OOMAOOMA INCA Award	Director	AAward	+11.6K sh	—	—	253,488
2025-05-29	Arcellx, Inc.Stock Option (right to buy)A Award	Director	AAward	+1,784 sh	—	—	1,784
2025-03-18	Arcellx, Inc.Stock Option (right to buy)A Award	Director	AAward	+16.8K sh	—	—	16,829
2024-12-17	OOMAOOMA INCM Exercise/Conversion	Director	MExercise/Conversion	+35K sh	$6.04	+$211K	256,756
2024-12-17	OOMAOOMA INC · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−35K sh	—	—	0
2024-12-17	OOMAOOMA INCS Sale	Director	SSale	−14.8K sh	$14.56	−$216K	241,932
2024-06-06	OOMAOOMA INCA Award	Director	AAward	+19.8K sh	—	—	221,833
2023-06-01	OOMAOOMA INCA Award	Director	AAward	+11.8K sh	—	—	202,071
2022-06-01	OOMAOOMA INCA Award	Director	AAward	+11.4K sh	—	—	190,288
2021-06-02	OOMAOOMA INCA Award	Director	AAward	+7,498 sh	—	—	178,933
2020-06-04	NEVRO CORPF Tax Payment	Chief Financial Officer	FTax Payment	−2,311 sh	$121.53	−$281K	59,179
2020-06-03	OOMAOOMA INCA Award	Director	AAward	+10.5K sh	—	—	171,435
2020-02-28	NEVRO CORPStock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−8,000 sh	—	—	33,394
2020-02-28	NEVRO CORPM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+8,000 sh	$3.60	+$28.8K	61,490
2020-01-08	NEVRO CORPStock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−17.7K sh	—	—	0
2020-01-08	NEVRO CORPS Sale	Chief Financial Officer	SSale	−17.7K sh	$120.11	−$2.13M	53,490
2020-01-08	NEVRO CORPM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+17.7K sh	$63.23	+$1.12M	71,208
2020-01-06	NEVRO CORPM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,782 sh	$63.23	+$176K	56,272
2020-01-06	NEVRO CORPS Sale	Chief Financial Officer	SSale	−2,782 sh	$120.00	−$334K	53,490
2020-01-06	NEVRO CORPStock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,782 sh	—	—	17,718
2019-11-25	NEVRO CORPS Sale	Chief Financial Officer	SSale	−12K sh	$110.39	−$1.32M	53,490
2019-11-25	NEVRO CORPStock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−12K sh	—	—	20,500
2019-11-25	NEVRO CORPM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+12K sh	$63.23	+$759K	65,490
2019-11-11	NEVRO CORPStock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−12K sh	—	—	32,500
2019-11-11	NEVRO CORPStock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−6,522 sh	—	—	14,941
2019-11-11	NEVRO CORPS Sale	Chief Financial Officer	SSale	−1,175 sh	$104.74	−$123K	53,490
2019-11-11	NEVRO CORPS Sale	Chief Financial Officer	SSale	−10.3K sh	$103.85	−$1.07M	54,665
2019-11-11	NEVRO CORPS Sale	Chief Financial Officer	SSale	−7,002 sh	$103.31	−$723K	65,010
2019-11-11	NEVRO CORPM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+12K sh	$63.23	+$759K	72,012
2019-11-11	NEVRO CORPM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+6,522 sh	$18.00	+$117K	60,012
2019-11-01	NEVRO CORPF Tax Payment	Chief Financial Officer	FTax Payment	−1,713 sh	$86.63	−$148K	53,490
2019-09-23	OOMAOOMA INCS Sale	Director	SSale	−25K sh	$10.50	−$262K	160,984
2019-09-10	OOMAOOMA INCS Sale	Director	SSale	−25K sh	$12.31	−$308K	185,984
2019-07-16	NEVRO CORPM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,500 sh	$3.60	+$9,000	55,203
2019-07-16	NEVRO CORPStock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,500 sh	—	—	41,394
2019-07-08	OOMAOOMA INCM Exercise/Conversion	Director	MExercise/Conversion	+19.2K sh	$0.90	+$17.2K	96,041
2019-07-08	OOMAOOMA INCM Exercise/Conversion	Director	MExercise/Conversion	+115K sh	$0.90	+$103K	210,984
2019-07-08	OOMAOOMA INC · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−19.2K sh	—	—	0
2019-07-08	OOMAOOMA INC · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−115K sh	—	—	0
2019-06-10	OOMAOOMA INCA Award	Director	AAward	+9,607 sh	—	—	76,884
2019-05-28	NEVRO CORPA Award	Chief Financial Officer	AAward	+8,564 sh	—	—	52,703
2019-01-04	NEVRO CORPM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+11K sh	$1.44	+$15.8K	44,139
2019-01-04	NEVRO CORPStock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−11K sh	—	—	0
2018-11-01	NEVRO CORPF Tax Payment	Chief Financial Officer	FTax Payment	−2,457 sh	$49.40	−$121K	33,135
2018-07-18	NEVRO CORPStock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−7,400 sh	—	—	11,004

Recent filings

Accepted (ET)
Jun 84
Galligan Andrew H0001193125-26-262429
SEC(opens sec.gov)
Apr 284
Galligan Andrew H0001417976-26-000002
SEC(opens sec.gov)
Jun 244
Galligan Andrew H0000950170-25-089617
SEC(opens sec.gov)
Jun 94
Galligan Andrew H0000950170-25-083984
SEC(opens sec.gov)
May 304
Galligan Andrew H0001415889-25-014994
SEC(opens sec.gov)
Mar 204
Galligan Andrew H0001415889-25-008692
SEC(opens sec.gov)
Dec 194
Galligan Andrew H0000950170-24-138441
SEC(opens sec.gov)
Jun 74
Galligan Andrew H0000950170-24-070502
SEC(opens sec.gov)
Jun 54
Galligan Andrew H0001209191-23-034665
SEC(opens sec.gov)
Jun 34
Galligan Andrew H0001209191-22-034131
SEC(opens sec.gov)
Jun 44
Galligan Andrew H0001209191-21-038371
SEC(opens sec.gov)
Jun 84
Galligan Andrew H0001567619-20-011851
SEC(opens sec.gov)
Jun 54
Galligan Andrew H0001209191-20-034841
SEC(opens sec.gov)
Mar 34
Galligan Andrew H0001567619-20-005412
SEC(opens sec.gov)
Jan 104
Galligan Andrew H0001567619-20-000906
SEC(opens sec.gov)

Companies

Address

C/O OOMA, INC. 525 ALMANOR AVE., SUITE 200

SUNNYVALE, CA, 94085